title: [Neurological toxicity from pentavalent antimonials during the treatment of visceral leishmaniasis].
authors.forename: P
authors.initials: P
authors.lastname: Laguna del Estal
authors.forename: S
authors.initials: S
authors.lastname: Calabrese
authors.forename: J A
authors.initials: JA
authors.lastname: Zabala
authors.forename: T
authors.initials: T
authors.lastname: Martín
mesh_terms: D000328:Adult; D000965:Antimony / Q000009:adverse effects*; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009122:Muscle Hypertonia / Q000139:chemically induced*; D014202:Tremor / Q000139:chemically induced*
chemical_list: D000981:Antiprotozoal Agents; D000965:Antimony
vernacular_title: Toxicidad neurológica por antimoniales pentavalentes durante el tratamiento de la leishmaniasis visceral.